Daratumumab

3 registered clinical trials studyying Daratumumab — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethaso NCT07015021	The First Affiliated Hospital of Soochow University	N/A
Completed	Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagn NCT05835726	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Unknown	Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma NCT04065308	Seoul National University Hospital	Phase 2